Search for Clinical Trial Results

Sponsored By

Optic Nerve Glioma - 10 Studies Found

Status Study
Withdrawn Study Name: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Condition: Optic Nerve Glioma
Date: 2010-12-13
Interventions:
  • Drug: Temozolomide Study subje
Active, not recruiting Study Name: PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
Condition:
  • Neurofibromatosis-1
  • Optic Glioma
  • Pilomyxoid Astrocytoma
  • Pilocytic Astrocytoma
  • Glioma, Astro
    Date: 2013-04-16
    Interventions:
    • Drug: Mebendazole Mebendazole

Withdrawn Study Name: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
Condition:
  • Astrocytoma
  • Brainstem Glioma
  • Ependymoma
  • Radiation: Radiation therapy
  • Drug: Temozol
Recruiting Study Name: Phase II Pegylated Interferon
Condition:
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas

Date: 2015-01-08
Interventions: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o
Not yet recruiting Study Name: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Dermal Neurofibroma
Condition:
  • Appearance Distress
  • Bothered by Itching Skin
  • Cafe Au Lait
    Date: 2016-07-20
    Interventions:
    • Other: Laboratory Biomarker Analysis

Active, not recruiting Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Condition:
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocytic Astrocytoma
  • Drug: Lenalidomide Given PO
Terminated Study Name: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
Condition:
  • neurofibromatosis1 (NF1)
  • Recurrent or Progressive Optic Pathway Gliomas (OPG)
  • Date: 2011-04-18
    Interventions: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will
Recruiting Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Condition:
  • Glioma
  • Neurofibromatosis Type 1
  • Recurrent Childhood Pilocy
    Date: 2010-03-17
    Interventions:
    • Other: Laboratory Biomarker Analysis